SERVICES
Deployment

ACCELERATING DEVELOPMENT OF SUCCESSFUL THERAPIES

Enhanced targeting, discovery and clinical trials with significantly reduced cost and time to market

 

Our deployment services span a number of steps, from target discovery to commercialization, designed to facilitate development of more efficacious, safer cell-based therapies for solid tumors. Our services help you accelerate and enhance your discovery, regulatory and commercialization efforts.

WHAT YOU GET WITH JAVELIN SERVICES

  • Exclusive focus and prioritization on high-probabilisitic targets
  • Reduced costs for design and development
  • A streamlined regulatory and clinical trial pathway with smaller trials at reduced costs with accelerated time to market
  • Optimized pricing and revenue models and patient targets with an ability to embrace risk based contracts 
Predicting success with Javelin services

THE GOLD STANDARD FOR DETERMINING SAFETY AND EFFICACY

Much of our selection process is based on our ability to predict a  therapy’s efficacy and safety profile to get an understanding of the likelihood of off-tumor, on-target toxicity. This process eliminates targets with little probability of success and allows you to focus efforts on developing treatments that work.

SIMPLIFY REGULATORY APPROVAL

Deployment services include assistance with clinical trial design and execution. Additionally, we can estimate the percentage of patients likely to respond to treatment and provide recommendations to improve targeting.  We analyze, identify and stratify patients for clinical trials to reduce enrollment needs. We can enable identification and enrollment of patients and sites. 

Deployment services

javelin-deployment-services

ASSISTANCE THROUGHOUT THE COMMERCIALIZATION PROCESS

With our own lab experience developing therapies and a set of proprietary tools we have developed, we create improvements that save you time and money at each step. The ultimate goal is to bring safe and effective therapies to the market at a faction of current costs and time.  Once a therapy is on the market, the same tools can match it with the patient population where it will have the greatest positive impact. 

JAVELIN STANDARD DEPLOYMENT SERVICES

Research and Development

  • Target characterization
  • Assessment of tumors accessibility barriers (patients resistant to therapy)
  • Modality assessment
  • Combination therapy potential
  • Safety evaluation and modulation

Clinical Trial  Development 

  • Match biomarker profile to potential therapies
  • Predict and stratify responders and non-responders to reduce census
  • Identify and enroll  patients and sites
  • Trial rescue

Commercial 

  • Match patients with approved therapies
  • Allow companies to embrace risk-based reimbursement
  • Help payers and providers determine which therapies work with which patients
  • Optimize overall development and commercialization approach

ADDITIONAL SERVICES

  • CAR production
  • Activation switches
  • Safety switches
  • Enhanced productivity tools
  • Licensing of Javelin tools

DIVE DEEPER

Learn more about how Javelin Oncology can help you accelerate your immuno-oncology therapy development pipeline

Assessment

Javelin assesses the level of saving and improvements that can be delivered


Deployment

Javelin works with you to deliver these savings and benefits with a minimum 5:1 ROI on Javelin fees. In some cases Javelin can help fund your efforts.

LEARN MORE ABOUT THE JAVELIN PLATFORM